PATENT CLAIM ANALYSIS

Application Number: 15744532
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["435", "007100"]

Abstract:
Provided is a composition including a combination of at least one short peptide and at least one peptide dimer, in defined ratio, to which autoantibodies found in elevated levels in schizophrenic patients bind.

Claim (Index 3):
The composition according to  claim 1 , wherein the compound of Formula (I) is of general Formula (II):\n X\u2014S\u2014S\u2014X\u2032 wherein each of X\u2032 and X is as defined in  claim 1 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.28571
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13701177', '15039681', '15994978', '14764419', '09793146']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5935710969263874
- 35 USC 102 Novelty (BERT): 0.494384793813544
- Combined Prediction Score: 0.5836524666151031
- Mean Citation Score: 181.942498
- Max Citation Score: 186.26022
- Similarity Product: 116.88678061622144

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test